Perspectives on cancer therapy-induced mucosal injury : Pathogenesis, measurement, epidemiology, and consequences for patients
✍ Scribed by Stephen T. Sonis; Linda S. Elting; Dorothy Keefe; Douglas E. Peterson; Mark Schubert; Martin Hauer-Jensen; B. Nebiyou Bekele; Judith Raber-Durlacher; J. Peter Donnelly; Edward B. Rubenstein
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 409 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
Dr. Sonis has served as a consultant for Biomodels and Affiliates, LLC (Wellesley, MA). Dr. Elting has received speaker's honoraria from McNeill Pharmaceuticals and Endo Pharmaceuticals (Chadds Ford, PA). Dr. Keefe has received research funding and speaker's honoraria from Amgen. Dr. Peterson has served as a paid consultant for Aesgen, Inc. (Princeton, NJ). Dr. Schubert is a member of the Advisory Boards for Endo Pharmaceuticals, OSI Pharmaceuticals, and McNeill Pharmaceuticals and has received consulting fees per meeting plus expenses. Dr. Rubenstein has received research funding from and is a member of the speakers program and advisory board at Merck (Whitehouse Station, NJ); he owns common stock in and is a member of the advisory board at MGI Pharma; and he is a member of the advisory boards at Endo Pharmaceuticals, McNeil Consumer and Specialty Pharmaceuticals, and OSI Pharmaceuticals.